The Pharmaceutical, Biotechnology and Life Sciences industries remain in an era of explosive growth with tremendous opportunity for innovation and investment. At the same time, both the incumbents and new entrants are facing tremendous challenges given the new realities of the economy. To read the entire whitepaper please visit: http://www.decisionlens.com/docs/WP_Decision_Making_in_Pharma_Biotech_LifeSciences.pdf
Some of the problems and challenges facing the industry are significant:
1) The costs of developing a New Chemical Entity (NCE) are steadily increasing without an increase in Return on Investment (ROI) in part due to strong price pressures.
2) Bridging the cultural and mindset differences between the research and operational camps in the businesses is increasing pressure in organizations and impacting the rates of both product development and new technology adoption.
3) Rapidly changing regulatory and compliance environments are increasing demands on information management and the technology.
To continue reading please visit: http://www.decisionlens.com/docs/WP_Decision_Making_in_Pharma_Biotech_LifeSciences.pdf
U3GM Blog Post Comments